Breathe Well Live Well
|
Mount Sinai and LifeMap Solutions Announce Initial Results for Asthma Health …
Newswise (press release) “We are delighted with the initial results we've seen after six months of using Apple's ResearchKit framework for our Asthma Health app,” said Eric Schadt, PhD, the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at … |
View full post on asthma – Google News
|
Time for a new language for asthma control: results from REALISE Asia
Dove Medical Press Purpose: Asthma is a global health problem, and asthma prevalence in Asia is increasing. The REcognise Asthma and LInk to Symptoms and Experience Asia study assessed patients' perception of asthma control and attitudes toward treatment in an … |
View full post on asthma – Google News
KTAL |
Unique new treatment approach is showing results for children with asthma
KTAL Data from 35,000 adolescent parent pairs showed teens were three times more likely to smoke and nearly twice as likely to become dependent on nicotine when their parent was a smoker. Daughters were especially vulnerable to their mother's smoking … |
View full post on asthma – Google News
MedCity News |
Asthma app study data on ResearchKit shows mixed results for patient …
MedCity News The company, a spin-off of LifeMap Sciences, noted that preliminary data for Asthma Health showed that more than half of users “not only complete the e-consent process, they also come back the very next day to use the app. This is a very high rate of … |
View full post on asthma – Google News
|
Skin-Prick Test Results May Predict Emerging Asthma
Medscape HOUSTON — Sensitivity to cats and dust mites, identified on skin-prick testing in children up to 4 years of age, might be an indicator of the risk of developing asthma by age 7, according to results of a new study. This finding could help guide … |
View full post on asthma – Google News
|
Positive results for Sanofi/Regeneron's dupilumab in asthma
The Pharma Letter French pharma major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals (Nasdaq: REGN) have released positive results from the interim analysis of a dose-ranging Phase IIb study of dupilumab in adult patients with uncontrolled … |
View full post on asthma – Google News
|
Omalizumab use in pregnancy showed comparable birth results with asthma …
Healio Prevalence of congenital defects, prematurity and low birth weight in infants of mothers treated with omalizumab during pregnancy were comparable with the general population with asthma, according to recent study results. “Asthma affected 8.4% to 8.8 … |
View full post on asthma – Google News
|
AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and … AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster AstraZeneca share price: Novel drug shows positive results for severe asthma AstraZeneca's benralizumab succeeds in severe asthma |
View full post on asthma – Google News
DNAinfo |
Asthma Study Results to Be Presented at Public Meeting in Englewood
DNAinfo According to the nonprofit Merck Childhood Asthma Network in Washington, D.C., asthma-related hospitalizations in Englewood and West Englewood are among the highest in Chicago, at 60 percent and 71 percent of hospitalizations in the area, more than … |
View full post on asthma – Google News
|
Positive Results for Reslizumab in Asthma Trials
Monthly Prescribing Reference Teva announced positive results from its Phase 3 studies of reslizumab in patients with uncontrolled moderate to severe asthma with elevated eosinophils, treated with standard of care therapies. Reslizumab is an investigational humanized monoclonal … Teva's Asthma Drug 'Significantly' Improves Lung Function In Phase 3 Trials |
View full post on asthma – Google News